Powered By
Overview
Pomalyst is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma that has progressed after being treated with other therapies. Pomalyst is often combined with a… read more
Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma. Revlimid is often combined with a corticosteroid like dexamethasone to treat newly… read more
Overview
Tecvayli is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory multiple myeloma. It may be used in combination with daratumumab hyaluronidase-fihj in…
Overview
Blenrep is approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who have received at least two prior treatments, including a proteasome inhibitor…
Join
